AstraZeneca PLC (AZN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 29.61B | 28.72B | 29.94B | 28.94B | 26.14B | 25.83B | 24.16B | 25.39B | 25.59B | 25.05B | 22.5B | 22.84B |
| Cash & Short-Term Investments | 7.67B | 5.74B | 8.18B | 7.11B | 5.39B | 5.65B | 4.93B | 7.08B | 8.02B | 5.86B | 5.12B | 5.81B |
| Cash Only | 7.56B | 5.71B | 8.14B | 7.06B | 5.23B | 5.49B | 4.8B | 6.92B | 7.84B | 5.84B | 4.87B | 5.66B |
| Short-Term Investments | 115M | 30M | 39M | 50M | 165M | 166M | 133M | 160M | 180M | 20M | 244M | 148M |
| Accounts Receivable | 14.11B | 15.18B | 14.34B | 14.17B | 13.25B | 12.97B | 11.88B | 11.05B | 11.07B | 10.51B | 11.3B | 11.09B |
| Days Sales Outstanding | 86.19 | 87.58 | 86.32 | 87.24 | 85.88 | 76.77 | 77.74 | 77.79 | 77.45 | 83.43 | 89.63 | 85.22 |
| Inventory | 6.57B | 6.56B | 6.59B | 6.47B | 5.88B | 5.29B | 5.66B | 5.67B | 5.34B | 5.42B | 5.29B | 5.05B |
| Days Inventory Outstanding | 220.58 | 194 | 214.48 | 229.74 | 221.84 | 184.84 | 169.14 | 229.35 | 220.75 | 213.58 | 227.1 | 232.56 |
| Other Current Assets | 1.26B | 1.25B | 827M | 1.2B | 1.61B | 1.91B | 1.68B | 1.6B | 1.16B | 1.64B | 794M | 884M |
| Total Non-Current Assets | 84.4B | 85.35B | 84.52B | 83.48B | 80.11B | 78.21B | 80.77B | 78.95B | 76.7B | 76.06B | 73.58B | 73.7B |
| Property, Plant & Equipment | 14.94B | 14.7B | 13.78B | 13.23B | 12.3B | 11.65B | 11.51B | 10.83B | 10.62B | 10.5B | 9.7B | 9.62B |
| Fixed Asset Turnover | 1.03x | 1.09x | 1.12x | 1.13x | 1.13x | 1.29x | 1.21x | 1.21x | 1.20x | 1.19x | 1.19x | 1.19x |
| Goodwill | 21.19B | 21.24B | 21.22B | 21.22B | 21.13B | 21.02B | 21.14B | 21.06B | 19.98B | 20.05B | 19.94B | 19.96B |
| Intangible Assets | 36.91B | 37.85B | 38.19B | 37.92B | 37.55B | 37.18B | 39.39B | 39.43B | 38.83B | 38.09B | 37.69B | 38.33B |
| Long-Term Investments | 4.24B | 2.52B | 2.29B | 4.85B | 1.9B | 1.73B | 2.01B | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.52B | 3.21B | 9.04B | 0 | 1.14B | 1.28B | 1.37B | 2.89B | 2.65B | 2.71B | 2.2B | 2.06B |
| Total Assets | 114.02B | 114.07B | 114.46B | 112.42B | 106.25B | 104.03B | 104.92B | 104.34B | 102.29B | 101.12B | 96.09B | 96.54B |
| Asset Turnover | 0.13x | 0.14x | 0.13x | 0.13x | 0.13x | 0.14x | 0.13x | 0.13x | 0.12x | 0.12x | 0.12x | 0.12x |
| Asset Growth % | 7.31% | 9.65% | 9.09% | 7.75% | 3.87% | 2.88% | 9.2% | 8.08% | 5.8% | 4.81% | 2.02% | -0.04% |
| Total Current Liabilities | 32.57B | 30.62B | 34.05B | 33.54B | 29.13B | 27.87B | 25.93B | 28.57B | 28.9B | 30.54B | 28.59B | 26.38B |
| Accounts Payable | 22.5B | 25.28B | 25.03B | 23.99B | 22.54B | 22.46B | 21.68B | 20.46B | 19.7B | 3.27B | 20.54B | 19.74B |
| Days Payables Outstanding | 802.96 | 742.2 | 804.94 | 865.5 | 893.75 | 745.27 | 629.26 | 837.09 | 471.12 | 474.53 | 884.43 | 904.15 |
| Short-Term Debt | 7.58B | 3.19B | 6.2B | 6.49B | 3.42B | 2.16B | 1.25B | 5.07B | 6.05B | 5.13B | 5.37B | 4.56B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 807M | 686M | 1.18B | 1.27B | 2.81B | 1.5B | 1.2B | 1.22B | 1.24B | 17.52B | 1.28B | 650M |
| Current Ratio | 0.91x | 0.94x | 0.88x | 0.86x | 0.90x | 0.93x | 0.93x | 0.89x | 0.89x | 0.82x | 0.79x | 0.87x |
| Quick Ratio | 0.71x | 0.72x | 0.69x | 0.67x | 0.70x | 0.74x | 0.71x | 0.69x | 0.70x | 0.64x | 0.60x | 0.67x |
| Cash Conversion Cycle | -496.18 | -460.62 | -504.14 | -548.52 | -586.03 | -483.66 | -382.38 | -529.95 | -172.93 | -177.52 | -567.7 | -586.37 |
| Total Non-Current Liabilities | 34.06B | 34.74B | 34.43B | 34.08B | 35.99B | 35.3B | 38.19B | 36.18B | 35.89B | 31.41B | 30.28B | 32.75B |
| Long-Term Debt | 24.45B | 24.71B | 24.7B | 24.71B | 26.74B | 26.51B | 28.89B | 27.23B | 27.26B | 22.36B | 22.23B | 24.33B |
| Capital Lease Obligations | 1.5B | 1.42B | 1.38B | 1.27B | 1.2B | 1.11B | 1.1B | 949M | 961M | 857M | 744M | 722M |
| Deferred Tax Liabilities | 3.47B | 3.5B | 3.6B | 3.62B | 0 | 3.31B | 3.57B | 3.33B | 2.62B | 2.84B | 2.75B | 2.8B |
| Other Non-Current Liabilities | 4.63B | 5.1B | 4.75B | 4.47B | 8.06B | 4.37B | 4.63B | 4.67B | 5.05B | 5.34B | 4.56B | 4.9B |
| Total Liabilities | 66.63B | 65.36B | 68.48B | 67.61B | 65.12B | 63.16B | 64.12B | 64.74B | 64.79B | 61.95B | 58.87B | 59.13B |
| Total Debt | 33.92B | 29.7B | 32.66B | 32.84B | 31.72B | 30.11B | 31.56B | 33.53B | 34.55B | 28.62B | 28.58B | 29.84B |
| Net Debt | 26.36B | 23.99B | 24.52B | 25.78B | 26.49B | 24.63B | 26.77B | 26.62B | 26.71B | 22.78B | 23.7B | 24.17B |
| Debt / Equity | 0.72x | 0.61x | 0.71x | 0.73x | 0.77x | 0.74x | 0.77x | 0.85x | 0.92x | 0.73x | 0.77x | 0.80x |
| Debt / EBITDA | 6.04x | 6.62x | 6.36x | 6.71x | 6.40x | 10.95x | 8.05x | 8.33x | 7.91x | 11.18x | 8.83x | 8.00x |
| Net Debt / EBITDA | 4.70x | 5.34x | 4.78x | 5.26x | 5.34x | 8.95x | 6.82x | 6.61x | 6.11x | 8.90x | 7.33x | 6.48x |
| Interest Coverage | 10.96x | 6.57x | 8.47x | 8.12x | 10.75x | 4.88x | 5.00x | 6.41x | 7.78x | 3.02x | 5.21x | 5.84x |
| Total Equity | 47.38B | 48.72B | 45.97B | 44.81B | 41.13B | 40.87B | 40.8B | 39.6B | 37.5B | 39.17B | 37.22B | 37.42B |
| Equity Growth % | 15.2% | 19.2% | 12.66% | 13.16% | 9.68% | 4.35% | 9.63% | 5.83% | 4.72% | 5.69% | 5.88% | 4.08% |
| Book Value per Share | 30.35 | 31.19 | 29.45 | 28.74 | 26.35 | 26.17 | 26.16 | 25.38 | 24.04 | 25.09 | 23.86 | 23.98 |
| Total Shareholders' Equity | 47.33B | 48.67B | 45.89B | 44.72B | 41.04B | 40.79B | 40.72B | 39.51B | 37.45B | 39.14B | 37.2B | 37.39B |
| Common Stock | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 387M | 387M |
| Retained Earnings | 9.67B | 10.97B | 8.21B | 7.02B | 3.36B | 3.16B | 3.14B | 1.85B | -212M | 1.5B | -434M | -234M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 2.04B | 2.07B | 2.05B | 0 | 1.99B | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 51M | 52M | 83M | 91M | 92M | 85M | 86M | 86M | 56M | 23M | 24M | 24M |